Gain-of-Function Variants in PLAAT4 and Spinal Predominant Demyelinating Leukodystrophy
This study found that PLAAT4 variants delineated SPDMLS, a clinically distinct leukodystrophy that should be considered in patients with unexplained spastic paraplegia and CNS WMH. Arachidonic acid-related lipids represent a candidate biomarker (measurable biological signal) for disease progression.
Real-World Observation
Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.